Advertisement
U.S. markets open in 6 hours 28 minutes

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.90000.0000 (0.00%)
At close: 04:00PM EDT
2.0000 +0.10 (+5.26%)
After hours: 06:40PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
93.17M71.49M111.98M42.38M39.57M
Enterprise Value
62.70M36.47M79.81M2.68M-7.18M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
2.101.452.290.760.61
Enterprise Value/Revenue
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-2.70-6.60-14.29-0.411.29

Trading Information

Stock Price History

Beta (5Y Monthly) 1.04
52-Week Change 3177.37%
S&P500 52-Week Change 328.64%
52 Week High 34.1900
52 Week Low 30.6070
50-Day Moving Average 32.1423
200-Day Moving Average 31.9845

Share Statistics

Avg Vol (3 month) 3209.01k
Avg Vol (10 day) 3200.97k
Shares Outstanding 549.04M
Implied Shares Outstanding 649.04M
Float 834.4M
% Held by Insiders 13.89%
% Held by Institutions 139.97%
Shares Short (Feb 29, 2024) 41.27M
Short Ratio (Feb 29, 2024) 46.21
Short % of Float (Feb 29, 2024) 43.45%
Short % of Shares Outstanding (Feb 29, 2024) 42.60%
Shares Short (prior month Jan 31, 2024) 41.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sep 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.94%
Return on Equity (ttm)-55.41%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23M
Net Income Avi to Common (ttm)-30.19M
Diluted EPS (ttm)-0.6400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.17M
Total Cash Per Share (mrq)0.66
Total Debt (mrq)1.69M
Total Debt/Equity (mrq)3.82%
Current Ratio (mrq)4.53
Book Value Per Share (mrq)0.90

Cash Flow Statement

Operating Cash Flow (ttm)-26.32M
Levered Free Cash Flow (ttm)-18.24M